Identification and characterization of two novel alternatively spliced E2F1 transcripts in the rat CNS

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The transcription factor E2F1 is known for cell cycle regulation and apoptosis, particularly in neurodegenerative diseases.
• Its precise role and regulation in the mature central nervous system (CNS) remain largely uncharacterized.
• Alternative splicing is a key mechanism for generating molecular diversity in the CNS.

Purpose of the Study:

• To identify and characterize novel alternatively spliced transcripts of E2F1 in the CNS.
• To investigate the expression patterns and regulation of these novel E2F1 variants.
• To explore the potential for these variants to produce functional proteins.

Main Methods:

• Identification and characterization of novel E2F1 splice variants (E2F1b and E2F1c) using molecular biology techniques.
• Analysis of E2F1 transcript expression in various neural cell types and during neuroglial cell maturation.
• Pharmacological manipulation (translation inhibition) and stimulation (high potassium chloride) to assess E2F1 transcript regulation.
• In vitro expression studies to confirm protein production from novel transcripts.

Main Results:

• Two novel alternatively spliced E2F1 transcripts, E2F1b (retaining intron 5) and E2F1c (excluding exon 6), were identified in brain tissue and neural cells.
• Expression of E2F1 transcripts varied during the maturation of primary hippocampal neuroglial cells.
• Global translation inhibition reduced the expression of E2F1a, E2F1b, and E2F1c.
• Elevated neuronal activity selectively increased E2F1b expression.
• In vitro studies confirmed that the novel transcripts can be translated into protein products.

Conclusions:

• The study identified novel, physiologically relevant alternatively spliced E2F1 transcripts in the CNS.
• These variants exhibit distinct expression patterns and regulatory responses to cellular conditions and neuronal activity.
• The findings suggest that E2F1 splice variants may play unique roles in the mature central nervous system, warranting further functional investigation.